After successfully completing Simya I with 12 investments, we launched our fundraising process for Simya II in mid-2024. While advancing our fundraising, we have also continued to meet new startups, conduct evaluations, and hold ongoing discussions with investors. We remain actively involved in the follow-on rounds of our portfolio companies as well.
Since the beginning of 2025, we’ve met with many startups and had the chance to get to know some of the most exciting ones more closely. Today, we are thrilled to share the result of this journey with you: our new investment in Reprai.
Reprai: Redefining Pharma Engagement with AI
Pharmaceutical sales have long relied on in-person visits. This approach is costly and inefficient as access to healthcare professionals is becoming increasingly challenging, and digital expectations are growing rapidly. reprai, an AI-powered engagement platform, addresses these challenges head-on.
As Simya VC, we’re investing $500,000 to support reprai in strengthening its technology and accelerating its global scale growth, starting with Europe and the United States.
What Does Reprai Do?
reprai enables pharmaceutical companies to engage healthcare professionals using personalized, AI-driven, 24/7 interactions, replacing costly, inefficient sales visits. Its reREP module delivers timely, relevant messages, while reTOOLS centralizes digital channels for effective, measurable engagement.
Healthcare professionals get instant, accurate product information with reprai, while pharma companies reduce engagement costs from $600 to under $20 per meeting.
What Makes Reprai Stand Out
The pharmaceutical industry has long recognized the need for digital transformation, but scalable, compliant, and truly impactful solutions have been rare. Reprai fills this gap with an AI-first approach. The founders, Didem Aral and Özhan Öztürk, along with technology leaders Cihan Şahin and Charles Randall, possess outstanding expertise in industry knowledge and technology.
The combination of a scalable business model, early product–market fit, and perfect timing positions Reprai to become a major player in the global market.
The Vision
reprai will use this investment to enhance its AI capabilities, roll out new product modules, expand across European and U.S. markets, and grow its team. At Simya VC, we’re confident that reprai will set the standard in a market that has yet to fully embrace digital transformation
Zeynep Şener
Simya VC